{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:58:24Z","timestamp":1793995104858,"version":"4.8.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04049-8","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T17:47:20Z","timestamp":1742492840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of a multiple urinary biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA Nephropathy"],"prefix":"10.1186","volume":"26","author":[{"given":"Jorge","family":"Gonz\u00e1lez Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"Valdivielso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00edas","family":"Jatem Escalante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Borr\u00e0s Sans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Garc\u00eda Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Del Carpio Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Muijsenberg Alcal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Pinyol Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ostos Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons","family":"Segarra Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Mart\u00edn Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"1","key":"4049_CR1","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1038\/s41598-020-77736-1","volume":"11","author":"C Kawakita","year":"2021","unstructured":"Kawakita C, Mise K, Onishi Y, Sugiyama H, Yoshida M, Yamada M, Wada J. Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy. Sci Rep. 2021;11(1):3394.","journal-title":"Sci Rep"},{"key":"4049_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0272-6386(12)80284-8","volume":"18","author":"E Alamartine","year":"1991","unstructured":"Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am J Kidney Dis. 1991;18:12\u20139.","journal-title":"Am J Kidney Dis"},{"key":"4049_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/ajkd.2000.8966","volume":"36","author":"G D\u2019Amico","year":"2000","unstructured":"D\u2019Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am JKidney Dis. 2000;36:227\u201337.","journal-title":"Am JKidney Dis"},{"key":"4049_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/ajkd.2001.27689","volume":"38","author":"LP Bartosik","year":"2001","unstructured":"Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis. 2001;38:728\u201335.","journal-title":"Am J Kidney Dis"},{"key":"4049_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1681\/ASN.2010040355","volume":"22","author":"F Berthoux","year":"2011","unstructured":"Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L. Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol. 2011;22:752\u201361.","journal-title":"J Am Soc Nephrol"},{"key":"4049_CR6","doi-asserted-by":"crossref","unstructured":"Espinosa M, Ortega R, S\u00e1nchez M, Segarra A, Salcedo MT,Gonz\u00e1lez F, et al., Spanish Group for Study of GlomerularDiseases (GLOSEN). Association of C4d deposition with clinical outcomes in IgA nephropathy. Clin J Am Soc Nephrol.2014;9:897\u2013904.","DOI":"10.2215\/CJN.09710913"},{"issue":"2","key":"4049_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2215\/CJN.02530317","volume":"13","author":"A Segarra","year":"2018","unstructured":"Segarra A, Romero K, Agraz I, Ramos N, Madrid A, Carnicer C, Jatem E, Vilalta R, Lara LE, Ostos E, Valtierra N, Jaramillo J, Arredondo KV, Ariceta G, Martinez C. Mesangial C4d deposits in early IgA nephropathy. Clin J Am Soc Nephrol. 2018;13(2):258\u201364.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"4049_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/his.13768","volume":"74","author":"MF Soares","year":"2019","unstructured":"Soares MF, Genitsch V, Chakera A, Smith A, MacEwen C, Bellur SS, Alham NK, Roberts ISD. Relationship between renal CD68+ infiltrates and the Oxford classification of IgA nephropathy. Histopathology. 2019;74(4):629\u201337.","journal-title":"Histopathology"},{"issue":"3","key":"4049_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5414\/CN107836","volume":"80","author":"M Stangou","year":"2013","unstructured":"Stangou M, Papagianni A, Bantis C, Moisiadis D, Kasimatis S, Spartalis M, Pantzaki A, Efstratiadis G, Memmos D. Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine. Clin Nephrol. 2013;80(3):203\u201310.","journal-title":"Clin Nephrol"},{"issue":"5","key":"4049_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.nefro.2016.11.017","volume":"37","author":"A Segarra-Medrano","year":"2017","unstructured":"Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor \u03b21 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy. Nefrologia. 2017;37(5):531\u20138.","journal-title":"Nefrologia"},{"issue":"2","key":"4049_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1053\/j.ackd.2013.12.002","volume":"21","author":"Y Caliskan","year":"2014","unstructured":"Caliskan Y, Kiryluk K. Novel biomarkers in glomerular disease. Adv Chronic Kidney Dis. 2014;21(2):205\u201316.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"4049_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3904\/kjim.2015.30.3.354","volume":"30","author":"H Rhee","year":"2015","unstructured":"Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy. Korean J Intern Med. 2015;30(3):354\u201361.","journal-title":"Korean J Intern Med"},{"issue":"11","key":"4049_CR13","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/ndt\/gfaa079","volume":"35","author":"IZA Pawluczyk","year":"2020","unstructured":"Pawluczyk IZA, Soares MSF, Barratt WA, Brown JR, Bhachu JS, Selvaskandan H, Zeng Y, Sarania R, Molyneux K, Roberts ISD, Barratt J. Macrophage interactions with collecting duct epithelial cells are capable of driving tubulointerstitial inflammation and fibrosis in immunoglobulin A nephropathy. Nephrol Dial Transplant. 2020;35(11):1865\u201377.","journal-title":"Nephrol Dial Transplant"},{"key":"4049_CR14","doi-asserted-by":"crossref","unstructured":"Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J,et al., VALIGA study of the ERA-EDTA Immunonephrology Working Group. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014;86:828\u201336.","DOI":"10.1038\/ki.2014.63"},{"issue":"5","key":"4049_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ki.2009.168","volume":"76","author":"IS Roberts","year":"2009","unstructured":"Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D\u2019Agati V, D\u2019Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546\u201356.","journal-title":"Kidney Int"},{"issue":"15","key":"4049_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1471-2369-15-107","volume":"7","author":"PC Xu","year":"2014","unstructured":"Xu PC, Wei L, Shang WY, Tian SL, Gu DM, Yan TK, Lin S. Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria. BMC Nephrol. 2014;7(15):107.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4049_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10157-018-1582-2","volume":"23","author":"H Suzuki","year":"2019","unstructured":"Suzuki H. Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis. Clin Exp Nephrol. 2019;23(1):26\u201331.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"4049_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3904\/kjim.2014.29.3.334","volume":"29","author":"JR Shin","year":"2014","unstructured":"Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG. Urinary excretion of \u03b22-microglobulin as a prognostic marker in immunoglobulin A nephropathy. Korean J Intern Med. 2014;29(3):334\u201340.","journal-title":"Korean J Intern Med"},{"issue":"2","key":"4049_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.clim.2007.01.010","volume":"123","author":"H Ding","year":"2007","unstructured":"Ding H, He Y, Li K, Yang J, Li X, Lu R, Gao W. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007;123(2):227\u201334.","journal-title":"Clin Immunol"},{"issue":"3","key":"4049_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10157-012-0707-2","volume":"17","author":"SH Kwon","year":"2013","unstructured":"Kwon SH, Park MY, Jeon JS, Noh H, Choi SJ, Kim JK, Hwang SD, Jin SY, Han DC. KIM-1 expression predicts renal outcomes in IgA nephropathy. Clin Exp Nephrol. 2013;17(3):359\u201364.","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"4049_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1159\/000087826","volume":"25","author":"T Nakamura","year":"2005","unstructured":"Nakamura T, Sugaya T, Ebihara I, Koide H. Urinary liver-type fatty acid-binding protein: discrimination between IgA nephropathy and thin basement membrane nephropathy. Am J Nephrol. 2005;25(5):447\u201350.","journal-title":"Am J Nephrol"},{"issue":"11","key":"4049_CR22","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1681\/ASN.2018040405","volume":"29","author":"S Zewinger","year":"2018","unstructured":"Zewinger S, Rauen T, Rudnicki M, Federico G, Wagner M, Triem S, Schunk SJ, Petrakis I, Schmit D, Wagenpfeil S, Heine GH, Mayer G, Floege J, Fliser D, Gr\u00f6ne HJ, Speer T. Dickkopf-3 (DKK3) in urine identifies patients with short-term risk of eGFR loss. J Am Soc Nephrol. 2018;29(11):2722\u201333.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"4049_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.ki.5002621","volume":"73","author":"DD Torres","year":"2008","unstructured":"Torres DD, Rossini M, Manno C, Mattace-Raso F, D\u2019Altri C, Ranieri E, Pontrelli P, Grandaliano G, Gesualdo L, Schena FP. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int. 2008;73(3):327\u201333.","journal-title":"Kidney Int"},{"issue":"6","key":"4049_CR24","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/ki.1996.521","volume":"50","author":"E Ranieri","year":"1996","unstructured":"Ranieri E, Gesualdo L, Petrarulo F, Schena FP. Urinary IL-6\/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy. Kidney Int. 1996;50(6):1990\u20132001.","journal-title":"Kidney Int"},{"issue":"6","key":"4049_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1440-1797.2008.01051.x","volume":"14","author":"M Stangou","year":"2009","unstructured":"Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, Economidou D, Leontsini M, Memmos D. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology (Carlton). 2009;14(6):613\u201320.","journal-title":"Nephrology (Carlton)"},{"key":"4049_CR26","doi-asserted-by":"crossref","unstructured":"Segarra A, Carnicer C, Jatem E, Martin M, Molina M, Perich C, Martinez C. Accuracy of Urinary Epidermal Growth Factor to Creatinine Ratio to Predict 24-Hour Urine Epidermal Growth Factor and Interstitial Kidney Fibrosis in Patients with IgA Nephropathy. Clin Lab. 2019;65(6).","DOI":"10.7754\/Clin.Lab.2018.181122"},{"key":"4049_CR27","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150:604\u201312.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"issue":"4","key":"4049_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/ki.2013.375","volume":"85","author":"M Haas","year":"2014","unstructured":"Haas M, Rastaldi MP, Fervenza FC. Histologic classification of glomerular diseases: linicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. Kidney Int. 2014;85(4):779\u201393.","journal-title":"Kidney Int"},{"issue":"1","key":"4049_CR29","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, James JA, Salto-Tellez M, Hamilton PW. QuPath: Open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878.","journal-title":"Sci Rep"},{"key":"4049_CR30","first-page":"565","volume":"106","author":"DW Hosmer","year":"1995","unstructured":"Hosmer DW, Lemeshow S. Confidence interval estimates of an index of quality performance based on logistic regression models. Stat Med. 1995;106:565\u201370.","journal-title":"Stat Med"},{"issue":"2019","key":"4049_CR31","first-page":"2424751","volume":"14","author":"Y Cao","year":"2019","unstructured":"Cao Y, Wang Y, Liu Y, Zhu X, Zhang G, Wang S, Chen X, Liu D, Fu C. Decreased expression of urinary mammalian target of rapamycin mRNA Is related to chronic renal fibrosis in IgAN. Dis Markers. 2019;14(2019):2424751.","journal-title":"Dis Markers"},{"issue":"4","key":"4049_CR32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.33549\/physiolres.933380","volume":"66","author":"P Prikryl","year":"2017","unstructured":"Prikryl P, Vojtova L, Maixnerova D, Vokurka M, Neprasova M, Zima T, Tesar V. Proteomic approach for identification of IgA nephropathy-related biomarkers in urine. Physiol Res. 2017;66(4):621\u201332.","journal-title":"Physiol Res"},{"issue":"14","key":"4049_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-2369-14-139","volume":"9","author":"MS Seo","year":"2013","unstructured":"Seo MS, Park MY, Choi SJ, Jeon JS, Noh H, Kim JK, Han DC, Hwang SD, Jin SY, Kwon SH. Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy. BMC Nephrol. 2013;9(14):139.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4049_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0272-6386(00)70295-2","volume":"35","author":"L Daniel","year":"2000","unstructured":"Daniel L, Saingra Y, Giorgi R, Bouvier C, Pellissier JF, Berland Y. Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis. 2000;35(1):13\u201320.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4049_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12882-017-0482-0","volume":"18","author":"S Liang","year":"2017","unstructured":"Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy. BMC Nephrol. 2017;18(1):63.","journal-title":"BMC Nephrol"},{"issue":"10","key":"4049_CR36","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1093\/ndt\/gfr023","volume":"26","author":"PC Xu","year":"2011","unstructured":"Xu PC, Zhang JJ, Chen M, Lv JC, Liu G, Zou WZ, Zhang H, Zhao MH. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. Nephrol Dial Transplant. 2011;26(10):3229\u201336.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"4049_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.krcp.2014.07.004","volume":"33","author":"YH Lee","year":"2014","unstructured":"Lee YH, Kim YG, Lee SH, Moon JY, Jeong KH, Lee TW, Ihm CG. Clinicopathological role of kidney injury molecule-1 in immunoglobulin A nephropathy. Kidney Res Clin Pract. 2014;33(3):139\u201343.","journal-title":"Kidney Res Clin Pract"},{"issue":"11","key":"4049_CR38","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1093\/ndt\/gfr135","volume":"26","author":"HP Peters","year":"2011","unstructured":"Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26(11):3581\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"4049_CR39","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1159\/000494442","volume":"43","author":"J Neuhaus","year":"2018","unstructured":"Neuhaus J, Bauer F, Fitzner C, Hilgers RD, Seibert F, Babel N, Doevelaar A, Eitner F, Floege J, Rauen T, Westhoff TH. Urinary biomarkers in the prediction of prognosis and treatment response in IgA nephropathy. Kidney Blood Press Res. 2018;43(5):1563\u201372.","journal-title":"Kidney Blood Press Res"},{"issue":"6","key":"4049_CR40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1159\/000452595","volume":"41","author":"S Worawichawong","year":"2016","unstructured":"Worawichawong S, Worawichawong S, Radinahamed P, Muntham D, Sathirapongsasuti N, Nongnuch A, Assanatham M, Kitiyakara C. Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as biomarkers for interstitial fibrosis and tubular atrophy in primary glomerulonephritis. Kidney Blood Press Res. 2016;41(6):997\u20131007.","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"4049_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s40620-016-0299-0","volume":"29","author":"D Maixnerova","year":"2016","unstructured":"Maixnerova D, Reily C, Bian Q, Neprasova M, Novak J, Tesar V. Markers for the progression of IgA nephropathy. J Nephrol. 2016;29(4):535\u201341.","journal-title":"J Nephrol"},{"key":"4049_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1098-2825(1998)12:1<1::AID-JCLA1>3.0.CO;2-F","volume":"12","author":"A Saitoh","year":"1998","unstructured":"Saitoh A, Suzuki Y, Takeda M, Kubota K, Itoh K, Tomino Y. Urinary levels of monocyte chemoattractant protein (MCP)-1 and disease activity in patients with IgA nephropathy. J Clin Lab Anal. 1998;12:1\u20135.","journal-title":"J Clin Lab Anal"},{"key":"4049_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jlb.63.4.493","volume":"63","author":"H Yokoyama","year":"1998","unstructured":"Yokoyama H, Wada T, Furuichi K, Segawa C, Shimizu M, et al. Urinary levels of chemokines (MCAF\/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy. J Leukoc Biol. 1998;63:493\u20139.","journal-title":"J Leukoc Biol"},{"key":"4049_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1081\/JDI-120021156","volume":"25","author":"T Morii","year":"2003","unstructured":"Morii T, Fujita H, Narita T, Koshimura J, Shimotomai T, et al. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases. Ren Fail. 2003;25:439\u201344.","journal-title":"Ren Fail"},{"key":"4049_CR45","first-page":"1023","volume":"34","author":"Y Sun","year":"2009","unstructured":"Sun Y, Yuan S, Xu X. Expression of MCP-1 in renal tissues of patients with IgA nephropathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009;34:1023\u20138.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"4049_CR46","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.cca.2011.07.023","volume":"412","author":"MJ Kim","year":"2011","unstructured":"Kim MJ, Tam FW. Urinary monocyte chemoattractant protein-1 in renal disease. Clin Chim Acta. 2011;412:2022\u201330.","journal-title":"Clin Chim Acta"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04049-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04049-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04049-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T19:28:44Z","timestamp":1742585324000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04049-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4049"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04049-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Jos\u00e9-Bruno Montoro Ronsano, Secretary from Vall d\u2019Hebron\u2019s University Hospital Research Institute in Barcelona (Spain), and its Ethical Committee, CERTIFICATES the aprovement of the Clinical Study with clinical code number SEG-CUC-2003\u201301 titled: \u201cAnalysis of urine and serum biomarkers related to the interstitial and glomerular fibrosis surface on glomerular and interstitial nephropathies\u201d. This study adhered to the parameters established by the Declaration of Helsinki. All patients gave their informed consent in writing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}